Summary & Overview
CPT 0096U: Male Urine High-Risk HPV PCR Assay
CPT code 0096U designates a Proprietary Laboratory Analyses (PLA) test: a Roche Cobas® automated PCR assay performed by Molecular Testing Labs for detection of 14 high–risk HPV genotypes from a male urine specimen. As a PLA code, 0096U identifies a single manufacturer- or lab-specific diagnostic service, which matters for coverage, coding clarity, and tracking of utilization for this specific test nationally. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. This publication provides an executive overview of the code’s clinical context, the service setting, and the implications of PLA designation for billing and payer engagement. Readers will find concise benchmarks on payer coverage patterns where available, summaries of relevant policy considerations for proprietary assays, and clinical context on use of urine-based high–risk HPV testing in males. Data not available in the input is noted where applicable. The content is intended to inform coding teams, laboratory billing staff, and policy analysts about the identification, classification, and typical service delivery setting for CPT code 0096U without providing clinical recommendations.
Billing Code Overview
CPT code 0096U is a Proprietary Laboratory Analyses (PLA) code for a specific high–risk human papillomavirus (HPV) test performed by Molecular Testing Labs using the Roche Cobas® automated PCR platform. The code applies exclusively to the single, manufacturer- or lab-specific assay that detects 14 high–risk HPV genotypes in a male urine specimen.
-
Service type: Laboratory molecular diagnostic test (automated PCR high–risk HPV assay)
-
Typical site of service: Clinical laboratory or reference laboratory processing urine specimens
Clinical & Coding Specifications
Clinical Context
A 28-year-old male presents to an outpatient urology or sexual health clinic requesting noninvasive screening for high‑risk human papillomavirus (HPV) after a partner has a recent abnormal cervical screening. A midstream urine specimen is collected in the clinic and sent to Molecular Testing Labs for analysis using the Roche Cobas® automated PCR platform. The test is a Proprietary Laboratory Analyses code reported as 0096U and identifies 14 high‑risk HPV genotypes. Typical workflow: order placed in the electronic health record, patient voids into a sterile container per collection instructions, specimen labeled and transported to the clinic laboratory or couriered to the reference lab, accessioning, automated PCR processing on the Roche Cobas® system, results routed back to the ordering clinician. Results are used for sexual health counseling, risk assessment, and possible referral for further evaluation if positive (for example, visual inspection or specialty referral). Typical site of service: outpatient clinic, ambulatory care center, or reference laboratory performing the test.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — default reporting | Use when no special circumstances or modifiers apply. |